The expanded indication makes olezarsen the first therapy approved to reduce the acute pancreatitis risk in adults with severe hypertriglyceridemia.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/fda-okays-drug-curb-acute-pancreatitis-severe-2026a1000lhk?src=rss
Author :
Publish date : 2026-06-24 19:41:00
Copyright for syndicated content belongs to the linked Source.